• 1. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 2. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 3. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 4. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 5. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455

Introduction to 3-Phenyl-1-tritylpiperazine (CAS No. 912763-28-1)

3-Phenyl-1-tritylpiperazine, identified by the Chemical Abstracts Service Number (CAS No.) 912763-28-1, is a significant compound in the realm of pharmaceutical chemistry and medicinal research. This compound belongs to the piperazine class, a heterocyclic amine characterized by a six-membered ring containing one nitrogen atom and two adjacent carbon atoms. The presence of a phenyl group at the 3-position and a trityl (triphenylmethyl) group at the 1-position confers unique chemical and pharmacological properties, making it a subject of considerable interest in drug discovery and development.

The trityl moiety, specifically, introduces steric hindrance and lipophilicity, which can influence the compound's solubility, metabolic stability, and interaction with biological targets. This structural feature is particularly relevant in designing molecules with enhanced pharmacokinetic profiles. In recent years, the exploration of piperazine derivatives has gained momentum due to their versatility in modulating various biological pathways, including neurotransmitter systems and enzyme inhibition.

One of the most compelling aspects of 3-Phenyl-1-tritylpiperazine is its potential as a scaffold for developing novel therapeutic agents. The piperazine core is a well-documented pharmacophore in many drugs used to treat conditions such as depression, schizophrenia, and ADHD. By modifying substituents like the phenyl and trityl groups, researchers can fine-tune the pharmacological activity of the compound. For instance, studies have shown that substituents at the 3-position of piperazine can significantly alter receptor binding affinity and selectivity.

Recent advancements in computational chemistry and high-throughput screening have facilitated the rapid identification of promising candidates like 3-Phenyl-1-tritylpiperazine. These techniques allow for the virtual screening of vast chemical libraries, enabling scientists to predict binding interactions with biological targets with high accuracy. This approach has been instrumental in accelerating drug discovery pipelines, particularly for complex diseases that require highly specific interventions.

The synthesis of 3-Phenyl-1-tritylpiperazine involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. The introduction of the trityl group necessitates careful consideration of reaction pathways to avoid side products that could complicate downstream applications. Modern synthetic methodologies, such as transition metal-catalyzed cross-coupling reactions, have improved the efficiency of these processes, making it feasible to produce complex molecules like this one on a larger scale.

In addition to its pharmaceutical applications, 3-Phenyl-1-tritylpiperazine has been explored for its potential role in biochemical research. Its unique structural features make it an excellent tool for studying enzyme mechanisms and receptor dynamics. For example, researchers have utilized this compound to investigate the binding kinetics of neurotransmitter receptors, providing insights into how these receptors contribute to neurological disorders.

The chemical stability of 3-Phenyl-1-tritylpiperazine is another critical factor that influences its utility in research and development. The trityl group can be susceptible to hydrolysis under certain conditions, which may affect long-term storage and handling. To mitigate this issue, stabilizers or protective groups may be employed during synthesis and purification. Advances in analytical chemistry have also enabled more accurate characterization of this compound using techniques such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry.

The pharmacological profile of 3-Phenyl-1-tritylpiperazine continues to be an area of active investigation. Preclinical studies have suggested that this compound exhibits moderate affinity for certain serotonin receptors, making it a candidate for developing treatments targeting serotonin-related disorders. However, further research is needed to fully elucidate its mechanism of action and potential side effects. Collaborative efforts between academic institutions and pharmaceutical companies are essential to bridge this gap between preclinical findings and clinical applications.

The regulatory landscape surrounding new chemical entities like 3-Phenyl-1-tritylpiperazine is stringent but well-established. Regulatory agencies require comprehensive data on safety, efficacy, and quality before approving a new drug or research chemical for use. This ensures that compounds like this one are thoroughly evaluated before being introduced into therapeutic or scientific contexts. Compliance with Good Manufacturing Practices (GMP) is particularly crucial for ensuring batch-to-batch consistency, which is vital for both research reproducibility and clinical safety.

The future prospects for 3-Phenyl-1-tritylpiperazine are promising given its unique structural features and potential therapeutic applications. As drug discovery technologies continue to evolve, this compound may find new uses in treating previously untreatable conditions or improving existing therapies. Additionally, its role as a biochemical probe could lead to novel insights into fundamental biological processes.

In conclusion,3-Phenyl-1-tritylpiperazine (CAS No. 912763-28-1) represents an intriguing molecule with significant potential in pharmaceutical chemistry and medicinal research. Its structural features offer opportunities for developing novel therapeutics while serving as a valuable tool in biochemical investigations. Continued research into its properties will likely uncover new applications that benefit both science and medicine.

• 41353-93-9(2,2-diphenylpiperazine)
• 102586-24-3(1,2-Propanediamine,N2,N2-dimethyl-N1-phenyl-N1-(phenylmethyl)-)
• 326594-27-8(1-Trityl-3-methylpiperazine)
• 918481-19-3(1-(1-Phenylethyl)-4-(2-phenylpropyl)piperazine)
• 885950-68-5(2-(4-Methylpiperazinyl)-1-phenylethylmethylamine)
• 102107-42-6(1,2-Ethanediamine,N1,N1-dimethyl-1,1-diphenyl-)
• 832155-10-9(Piperazine, 3-phenyl-1-(phenylmethyl)-, (3R)-)
• 313657-75-9((3R)-3-methyl-1-(triphenylmethyl)piperazine)
• 13157-36-3(Piperazine,2-methyl-2-phenyl-)
• 625843-74-5((3S)-3-methyl-1-(triphenylmethyl)piperazine)